{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:30:53Z","timestamp":1772559053639,"version":"3.50.1"},"reference-count":82,"publisher":"Walter de Gruyter GmbH","issue":"6","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801278"],"award-info":[{"award-number":["81801278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2019206637"],"award-info":[{"award-number":["H2019206637"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201608130015"],"award-info":[{"award-number":["201608130015"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008047","name":"Hebei University Science and technology research project","doi-asserted-by":"publisher","award":["ZD2019049"],"award-info":[{"award-number":["ZD2019049"]}],"id":[{"id":"10.13039\/501100008047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016083","name":"Hebei Provincial Department of Human Resources and Social Security","doi-asserted-by":"crossref","award":["C20190509"],"award-info":[{"award-number":["C20190509"]}],"id":[{"id":"10.13039\/100016083","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alzheimer's disease (AD) is a very common cause of dementia in the elderly. It is characterized by progressive amnesia and accretions of neurofibrillary tangles (NFTs) of neurons and senile plaques in the neuropil. After aging, the inheritance of the apolipoprotein E (ApoE) epsilon 4 (\u03b54) allele is the greatest risk factor for late-onset AD. The ApoE protein is the translated product of the ApoE gene. This protein undergoes proteolysis, and the resulting fragments colocalize with neurofibrillary tangles and amyloid plaques, and for that matter may be involved in AD onset and\/or progression. Previous studies have reported the pathogenic potential of various ApoE fragments in AD pathophysiology. However, the pathways activated by the fragments are not fully understood. In this review, ApoE fragments obtained from post-mortem brains and body fluids, cerebrospinal fluid (CSF) and plasma, are discussed. Additionally, current knowledge about the process of fragmentation is summarized. Finally, the mechanisms by which these fragments are involved in AD pathogenesis and pathophysiology are discussed.<\/jats:p>","DOI":"10.1515\/revneuro-2019-0115","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T07:51:47Z","timestamp":1597737107000},"page":"589-603","source":"Crossref","is-referenced-by-count":6,"title":["Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease"],"prefix":"10.1515","volume":"31","author":[{"given":"Asiamah Ernest","family":"Amponsah","sequence":"first","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofeng","family":"Feng","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyun","family":"Guo","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"He","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desheng","family":"Kong","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Dong","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Human Anatomy Department , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"China Human Anatomy Department , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixian","family":"Cui","sequence":"additional","affiliation":[{"name":"Hebei Medical University-National University of Ireland Galway Stem Cell Research Center , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"Hebei Research Center for Stem Cell Medical Translational Engineering , Shijiazhuang, 050017 , Hebei Province , China"},{"name":"China Human Anatomy Department , Hebei Medical University , Shijiazhuang, 050017 , Hebei Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2023040102342476829_j_revneuro-2019-0115_ref_001_w2aab3b7c73b1b6b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21: 383\u2013421, https:\/\/doi.org\/10.1016\/S0197-4580(00)00124-X.","DOI":"10.1016\/S0197-4580(00)00124-X"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_002_w2aab3b7c73b1b6b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Aono, M., Bennett, E.R., Kim, K.S., Lynch, J.R., Myers, J., Pearlstein, R.D., Warner, D.S., and Laskowitz, D.T. (2003). Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. Neuroscience. 116: 437\u2013445, https:\/\/doi.org\/10.1016\/s0306-4522(02)00709-1.","DOI":"10.1016\/S0306-4522(02)00709-1"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_003_w2aab3b7c73b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Baranello, R.J., Bharani, K.L., Padmaraju, V., Chopra, N., Lahiri, D.K., Greig, N.H., Pappolla, M.A.,and Sambamurti, K. (2015). Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease. Curr. Alzheimer Res. 12: 32\u201346, https:\/\/doi.org\/10.2174\/1567205012666141218140953.","DOI":"10.2174\/1567205012666141218140953"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_004_w2aab3b7c73b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Bekris, L.M., Yu, C.E., Bird, T.D., and Tsuang, D.W. (2010). Genetics of Alzheimer disease. J. Geriatr. Psychiatry. Neurol. 23: 213\u2013227, https:\/\/doi.org\/10.1177\/0891988710383571.","DOI":"10.1177\/0891988710383571"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_005_w2aab3b7c73b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., and Tanzi, R.E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39: 17\u201323, https:\/\/doi.org\/10.1038\/ng1934.","DOI":"10.1038\/ng1934"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_006_w2aab3b7c73b1b6b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Wang, C., and Huang, Y. (2011). C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice. Proc. Natl. Acad. Sci. U.S.A. 108: 4236\u20134241, https:\/\/doi.org\/10.1073\/pnas.1018381108.","DOI":"10.1073\/pnas.1018381108"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_007_w2aab3b7c73b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Brecht, W.J., Harris, F.M., Chang, S., Tesseur, I., Yu, G.Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., et al. (2004). Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice. J. Neurosci. 24: 2527\u20132534, https:\/\/doi.org\/10.1523\/jneurosci.4315-03.2004.","DOI":"10.1523\/JNEUROSCI.4315-03.2004"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_008_w2aab3b7c73b1b6b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813\u2013820, https:\/\/doi.org\/10.1038\/414813a.","DOI":"10.1038\/414813a"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_009_w2aab3b7c73b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Brownlee, M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625, https:\/\/doi.org\/10.2337\/diabetes.54.6.1615.","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_011_w2aab3b7c73b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Bruno, M.A., Mufson, E.J., Wuu, J., and Cuello, A.C. (2009). Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J. Neuropathol. Exp. Neurol. 68: 1309\u20131318, https:\/\/doi.org\/10.1097\/nen.0b013e3181c22569.","DOI":"10.1097\/NEN.0b013e3181c22569"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_012_w2aab3b7c73b1b6b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Chang, S., ran Ma, T., Miranda, R.D., Balestra, M.E., Mahley, R.W., and Huang, Y. (2005). Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 102: 18694\u201318699, https:\/\/doi.org\/10.1073\/pnas.0508254102.","DOI":"10.1073\/pnas.0508254102"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_013_w2aab3b7c73b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Chen, H.K., Liu, Z., Meyer-Franke, A., Brodbeck, J., Miranda, R.D., McGuire, J.G., Pleiss, M.A., Ji, Z.S., Balestra, M.E., Walker, D.W., et al. (2012). Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J. Biol. Chem. 287: 5253\u20135266, https:\/\/doi.org\/10.1074\/jbc.m111.276162.","DOI":"10.1074\/jbc.M111.276162"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_014_w2aab3b7c73b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Chen, J., Li, Q., and Wang, J. (2011). Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc. Natl. Acad. Sci. U.S.A 108: 14813\u201314818, https:\/\/doi.org\/10.1073\/pnas.1106420108.","DOI":"10.1073\/pnas.1106420108"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_015_w2aab3b7c73b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Chetty, P.S., Mayne, L., Lund-Katz, S., Englander, S.W., and Phillips, M.C. (2017). Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 114: 968\u2013973, https:\/\/doi.org\/10.1073\/pnas.1617523114.","DOI":"10.1073\/pnas.1617523114"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_016_w2aab3b7c73b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Cho, H.S., Hyman, B.T., Greenberg, S.M., and Rebeck, G.W. (2001). Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J. Neuropathol. Exp. Neurol. 60: 342\u2013349, https:\/\/doi.org\/10.1093\/jnen\/60.4.342.","DOI":"10.1093\/jnen\/60.4.342"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_017_w2aab3b7c73b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Chu, Q., Diedrich, J.K., Vaughan, J.M., Donaldson, C.J., Nunn, M.F., Lee, K.F., and Saghatelian, A. (2016). HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective. J. Am. Chem. Soc. 138: 9473\u20139478, https:\/\/doi.org\/10.1021\/jacs.6b03463.","DOI":"10.1021\/jacs.6b03463"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_018_w2aab3b7c73b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Clay, M.A., Anantharamaiah, G.M., Mistry, M.J., Balasubramaniam, A., and Harmony, J.A. (1995). Localization of a Domain in Apolipoprotein E with both Cytostatic and Cytotoxic Activity. Biochemistry. 34: 11142\u201311151, https:\/\/doi.org\/10.1021\/bi00035a020.","DOI":"10.1021\/bi00035a020"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_019_w2aab3b7c73b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Costantini, C., Scrable, H., and Puglielli, L. (2006). An aging pathway controls the TrkA to p75NTR receptor switch and amyloid \u03b2-peptide generation. EMBO J. 25: 1997\u20132006, https:\/\/doi.org\/10.1038\/sj.emboj.7601062.","DOI":"10.1038\/sj.emboj.7601062"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_020_w2aab3b7c73b1b6b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Crutcher, K.A., Clay, M.A., Scott, S.A., Tian, X., Tolar, M., and Harmony, J.A. (1994). Neurite degeneration elicited by apolipoprotein E peptides. Exp. Neurol. 130: 120\u2013126, https:\/\/doi.org\/10.1006\/exnr.1994.1191.","DOI":"10.1006\/exnr.1994.1191"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_021_w2aab3b7c73b1b6b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Cruts, M., van Duijn, C.M., Backhovens, H., Van den Broeck, M., Wehnert, A., Serneels, S., Sherrington, R., Hutton, M., Hardy, J., St George-Hyslop, P.H., et al. (1998). Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease. Hum. Mol. Genet. 7: 43\u201351, https:\/\/doi.org\/10.1093\/hmg\/7.1.43.","DOI":"10.1093\/hmg\/7.1.43"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_022_w2aab3b7c73b1b6b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Dafnis, I., Argyri, L., Sagnou, M., Tzinia, A., Tsilibary, E.C., Stratikos, E., and Chroni, A. (2016). The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific. Sci. Rep. 6: 30654, https:\/\/doi.org\/10.1038\/srep30654.","DOI":"10.1038\/srep30654"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_023_w2aab3b7c73b1b6b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"Dafnis, I., Raftopoulou, C., Mountaki, C., Megalou, E., Zannis, V.I., and Chroni, A. (2018). ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and A\u03b2 production independently of their cholesterol efflux capacity. Biochem. J. 475: 1839\u20131859, https:\/\/doi.org\/10.1042\/bcj20180068.","DOI":"10.1042\/BCJ20180068"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_024_w2aab3b7c73b1b6b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Dafnis, I., Stratikos, E., Tzinia, A., Tsilibary, E.C., Zannis, V.I., and Chroni, A. (2010). An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42. J. Neurochem. 115: 873\u2013884, https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06756.x.","DOI":"10.1111\/j.1471-4159.2010.06756.x"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_025_w2aab3b7c73b1b6b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Dafnis, I., Tzinia, A.K., Tsilibary, E.C., Zannis, V.I., and Chroni, A. (2012). An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines. Neuroscience. 210: 21\u201332, https:\/\/doi.org\/10.1016\/j.neuroscience.2012.03.013.","DOI":"10.1016\/j.neuroscience.2012.03.013"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_026_w2aab3b7c73b1b6b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Dong, L.M., and Weisgraber, K.H. (1996). Human Apolipoprotein E4 Domain Interaction. J. Biol. Chem. 271: 19053\u201319057, https:\/\/doi.org\/10.1074\/jbc.271.32.19053.","DOI":"10.1074\/jbc.271.32.19053"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_027_w2aab3b7c73b1b6b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Frieden, C., and Garai, K. (2012). Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 109: 8913\u20138918, https:\/\/doi.org\/10.1073\/pnas.1207022109.","DOI":"10.1073\/pnas.1207022109"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_028_w2aab3b7c73b1b6b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Frieden, C., Wang, H., and Ho, C.M.W. (2017). A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions. Proc. Natl. Acad. Sci. U.S.A. 114: 6292\u20136297, https:\/\/doi.org\/10.1073\/pnas.1705080114.","DOI":"10.1073\/pnas.1705080114"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_029_w2aab3b7c73b1b6b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"Gause, J.W., Day, R.J., Caraway, C.A., Poon, W.W., and Rohn, T.T. (2017). Evaluation of Apolipoprotein E Fragmentation as a Biomarker for Alzheimer's Disease. J. Neurol. Neurol. Disord. 3, https:\/\/doi.org\/10.15744\/2454-4981.3.204.","DOI":"10.15744\/2454-4981.3.204"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_030_w2aab3b7c73b1b6b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"Gay, E.A., Klein, R.C., and Yakel, J.L. (2006). Apolipoprotein E-derived peptides block alpha7 neuronal nicotinic acetylcholine receptors expressed in xenopus oocytes. J. Pharmacol. Exp. Ther. 316: 835\u2013842, https:\/\/doi.org\/10.1124\/jpet.105.095505.","DOI":"10.1124\/jpet.105.095505"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_031_w2aab3b7c73b1b6b1ab2b2c30Aa","doi-asserted-by":"crossref","unstructured":"Guo, T., Noble, W., and Hanger, D.P. (2017). Roles of tau protein in heh and disease. Acta Neuropathol. 133: 665\u2013704, https:\/\/doi.org\/10.1007\/s00401-017-1707-9.","DOI":"10.1007\/s00401-017-1707-9"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_032_w2aab3b7c73b1b6b1ab2b2c31Aa","doi-asserted-by":"crossref","unstructured":"Harris-White, M.E. and Frautschy, S.A. (2005). Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. CNS Neurol. Disord. Drug Targets. 4: 469\u2013480, https:\/\/doi.org\/10.2174\/156800705774322102.","DOI":"10.2174\/156800705774322102"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_033_w2aab3b7c73b1b6b1ab2b2c32Aa","doi-asserted-by":"crossref","unstructured":"Harris, F.M., Brecht, W.J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J.D., Masliah, E., Hopkins, P.C., Scearce-Levie, K., et al. (2003). Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 100: 10966\u201310971, https:\/\/doi.org\/10.1073\/pnas.1434398100.","DOI":"10.1073\/pnas.1434398100"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_034_w2aab3b7c73b1b6b1ab2b2c33Aa","doi-asserted-by":"crossref","unstructured":"Hauser, P.S. and Ryan, R.O. (2013). Impact of apolipoprotein E on Alzheimer's disease. Curr Alzheimer Res. 10: 809\u2013817, https:\/\/doi.org\/10.2174\/15672050113109990156.","DOI":"10.2174\/15672050113109990156"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_035_w2aab3b7c73b1b6b1ab2b2c34Aa","doi-asserted-by":"crossref","unstructured":"Heinisch, J.J. and Brandt, R. (2016). Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells. Microbial. Cell (Graz, Austria). 3: 135\u2013146, https:\/\/doi.org\/10.15698\/mic2016.04.489.","DOI":"10.15698\/mic2016.04.489"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_036_w2aab3b7c73b1b6b1ab2b2c35Aa","doi-asserted-by":"crossref","unstructured":"Hernandez-Zimbron, L.F., Luna-Munoz, J., Mena, R., Vazquez-Ramirez, R., Kubli-Garfias, C., Cribbs, D.H., Manoutcharian, K., and Gevorkian, G. (2012). Amyloid-\u03b2 peptide binds to cytochrome C oxidase subunit 1. PLoS One. 7: e42344, https:\/\/doi.org\/10.1016\/s0891-5849(99)90960-7.","DOI":"10.1371\/journal.pone.0042344"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_037_w2aab3b7c73b1b6b1ab2b2c36Aa","doi-asserted-by":"crossref","unstructured":"Hoe, H.S., Freeman, J., and Rebeck, G.W. (2006). Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons. Mol. Neurodegener. 1: 18, https:\/\/doi.org\/10.1186\/1750-1326-1-18.","DOI":"10.1186\/1750-1326-1-18"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_038_w2aab3b7c73b1b6b1ab2b2c37Aa","doi-asserted-by":"crossref","unstructured":"Huang, Y., Liu, X.Q., Wyss-Coray, T., Brecht, W.J., Sanan, D.A., and Mahley, R.W. (2001). Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U.S.A. 98: 8838\u20138843, https:\/\/doi.org\/10.1073\/pnas.151254698.","DOI":"10.1073\/pnas.151254698"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_039_w2aab3b7c73b1b6b1ab2b2c38Aa","doi-asserted-by":"crossref","unstructured":"Huang, Y. and Mahley, R.W. (2014). Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol. Dis. 72 Pt A: 3\u201312, https:\/\/doi.org\/10.1016\/j.nbd.2014.08.025.","DOI":"10.1016\/j.nbd.2014.08.025"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_040_w2aab3b7c73b1b6b1ab2b2c39Aa","doi-asserted-by":"crossref","unstructured":"Huang, Y.A., Zhou, B., Wernig, M., and Sudhof, T.C. (2017). ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion. Cell. 168: 427\u2013441, e421, https:\/\/doi.org\/10.3410\/f.727228791.793527976.","DOI":"10.1016\/j.cell.2016.12.044"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_041_w2aab3b7c73b1b6b1ab2b2c40Aa","doi-asserted-by":"crossref","unstructured":"Hugo, J. and Ganguli, M. (2014). Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med. 30: 421\u2013442, https:\/\/doi.org\/10.1016\/j.cger.2014.04.001.","DOI":"10.1016\/j.cger.2014.04.001"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_042_w2aab3b7c73b1b6b1ab2b2c41Aa","doi-asserted-by":"crossref","unstructured":"Huynh, T.V., Davis, A.A., Ulrich, J.D., and Holtzman, D.M. (2017). Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins. J. Lipid Res. 58: 824\u2013836, https:\/\/doi.org\/10.1194\/jlr.r075481.","DOI":"10.1194\/jlr.R075481"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_043_w2aab3b7c73b1b6b1ab2b2c42Aa","doi-asserted-by":"crossref","unstructured":"Jones, P.B., Adams, K.W., Rozkalne, A., Spires-Jones, T.L., Hshieh, T.T., Hashimoto, T., von Armin, C.A., Mielke, M., Bacskai, B.J., and Hyman, B.T. (2011). Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-\u03b2 in Human Alzheimer Brain. PLoS One. 6: e14586, https:\/\/doi.org\/10.1371\/journal.pone.0014586.","DOI":"10.1371\/journal.pone.0014586"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_044_w2aab3b7c73b1b6b1ab2b2c43Aa","doi-asserted-by":"crossref","unstructured":"Klein, R.C. and Yakel, J.L. (2004). Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience. 127: 563\u2013567, https:\/\/doi.org\/10.1016\/j.neuroscience.2004.05.045.","DOI":"10.1016\/j.neuroscience.2004.05.045"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_045_w2aab3b7c73b1b6b1ab2b2c44Aa","doi-asserted-by":"crossref","unstructured":"Kockx, M., Jessup, W., and Kritharides, L. (2008). Regulation of endogenous apolipoprotein E secretion by macrophages. Arter. Thromb. Vasc. Biol. 28: 1060\u20131067, https:\/\/doi.org\/10.1161\/atvbaha.108.164350.","DOI":"10.1161\/ATVBAHA.108.164350"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_046_w2aab3b7c73b1b6b1ab2b2c45Aa","doi-asserted-by":"crossref","unstructured":"Kosik, K.S., Joachim, C.L., and Selkoe, D.J. (1987). Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1, https:\/\/doi.org\/10.1097\/00002093-198701030-00022.","DOI":"10.1097\/00002093-198701030-00022"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_047_w2aab3b7c73b1b6b1ab2b2c46Aa","doi-asserted-by":"crossref","unstructured":"Kumar, A., Singh, A., and Ekavali (2015). A review on Alzheimer's disease pathophysiology and its management: An update. Pharmacol. Rep. 67: 195\u2013203, https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004.","DOI":"10.1016\/j.pharep.2014.09.004"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_048_w2aab3b7c73b1b6b1ab2b2c47Aa","doi-asserted-by":"crossref","unstructured":"LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S., and Frail, D.E. (1994). Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269: 23403\u201323406, https:\/\/doi.org\/10.1016\/s0169-328x(96)00196-9.","DOI":"10.1016\/S0021-9258(17)31529-6"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_049_w2aab3b7c73b1b6b1ab2b2c48Aa","doi-asserted-by":"crossref","unstructured":"Laskowitz, D.T., Thekdi, A.D., Thekdi, S.D., Han, S.K., Myers, J.K., Pizzo, S.V., and Bennett, E.R. (2001). Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides. Exp. Neurol. 167: 74\u201385, https:\/\/doi.org\/10.1006\/exnr.2001.7541.","DOI":"10.1006\/exnr.2001.7541"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_050_w2aab3b7c73b1b6b1ab2b2c49Aa","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, L., Barger, S.W., and Griffin, W.S.T. (2003). Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23: 1605\u20131611, https:\/\/doi.org\/10.1523\/jneurosci.23-05-01605.2003.","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_051_w2aab3b7c73b1b6b1ab2b2c50Aa","doi-asserted-by":"crossref","unstructured":"Liao, F., Yoon, H., and Kim, J. (2017). Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Curr. Opin. Lipidol. 28: 60\u201367, https:\/\/doi.org\/10.1097\/mol.0000000000000383.","DOI":"10.1097\/MOL.0000000000000383"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_052_w2aab3b7c73b1b6b1ab2b2c51Aa","unstructured":"Love, J.E., Day, R.J., Gause, J.W., Brown, R.J., Pu, X., Theis, D.I., Caraway, C.A., Poon, W.W., Rahman, A.A., Morrison, B.E., et al. (2017). Nuclear uptake of an amino-terminal fragment of apolipoprotein E4 promotes cell death and localizes within microglia of the alzheimer's disease brain. Int. J. Physiol. Pathophysiol. Pharmacol. 9: 40\u201357. PMID: 28533891."},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_053_w2aab3b7c73b1b6b1ab2b2c52Aa","doi-asserted-by":"crossref","unstructured":"Lynch, J.R., Tang, W., Wang, H., Vitek, M.P., Bennett, E.R., Sullivan, P.M., Warner, D.S., and Laskowitz, D.T. (2003). APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278: 48529\u201348533, https:\/\/doi.org\/10.1074\/jbc.m306923200.","DOI":"10.1074\/jbc.M306923200"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_054_w2aab3b7c73b1b6b1ab2b2c53Aa","doi-asserted-by":"crossref","unstructured":"Mahley, R.W. (2016). Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arter. Thromb. Vasc. Biol. 36: 1305\u20131315, https:\/\/doi.org\/10.1161\/atvbaha.116.307023.","DOI":"10.1161\/ATVBAHA.116.307023"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_055_w2aab3b7c73b1b6b1ab2b2c54Aa","doi-asserted-by":"crossref","unstructured":"Manelli, A.M., Stine, W.B., Van Eldik, L.J., and LaDu, M.J. (2004). ApoE and A\u03b21\u201342 Interactions: Effects of Isoform and Conformation on Structure and Function. J. Mol. Neurosci. 23: 235\u2013246, https:\/\/doi.org\/10.1385\/jmn:23:3:235.","DOI":"10.1385\/JMN:23:3:235"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_056_w2aab3b7c73b1b6b1ab2b2c55Aa","doi-asserted-by":"crossref","unstructured":"Marques, M.A., Tolar, M., Harmony, J.A., and Crutcher, K.A. (1996). A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. NeuroReport. 7: 2529\u20132532, https:\/\/doi.org\/10.1097\/00001756-199611040-00025.","DOI":"10.1097\/00001756-199611040-00025"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_057_w2aab3b7c73b1b6b1ab2b2c56Aa","doi-asserted-by":"crossref","unstructured":"Masters, C.L., Bateman, R., Blennow, K., Rowe, C.C., Sperling, R.A., and Cummings, J.L. (2015). Alzheimer's disease Nat. Rev. Dis. Primers. 1: 15056, https:\/\/doi.org\/10.4324\/9780203330227_chapter_2.","DOI":"10.1038\/nrdp.2015.56"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_058_w2aab3b7c73b1b6b1ab2b2c57Aa","doi-asserted-by":"crossref","unstructured":"Morrow, J.A., Hatters, D.M., Lu, B., Hochtl, P., Oberg, K.A., Rupp, B., and Weisgraber, K.H. (2002). Apolipoprotein E4 forms a molten globule: A potential basis for its association with disease. J. Biol. Chem. 277: 50380\u201350385, https:\/\/doi.org\/10.1074\/jbc.m204898200.","DOI":"10.1074\/jbc.M204898200"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_059_w2aab3b7c73b1b6b1ab2b2c58Aa","doi-asserted-by":"crossref","unstructured":"Morrow, J.A., Segall, M.L., Lund-Katz, S., Phillips, M.C., Knapp, M., Rupp, B., and Weisgraber, K.H. (2000). Differences in Stability among the Human Apolipoprotein E Isoforms Determined by the Amino-Terminal Domain. Biochemistry. 39: 11657\u201311666, https:\/\/doi.org\/10.1021\/bi000099m.","DOI":"10.1021\/bi000099m"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_060_w2aab3b7c73b1b6b1ab2b2c59Aa","doi-asserted-by":"crossref","unstructured":"Mouchard, A., Boutonnet, M.C., Mazzocco, C., Biendon, N., Macrez, N., and Neuro, C.E.B.N.N. (2019). ApoE-fragment\/A\u03b2 heteromers in the brain of patients with Alzheimer's disease. Sci. Rep. 9: 3989, https:\/\/doi.org\/10.1038\/s41598-019-40438-4.","DOI":"10.1038\/s41598-019-40438-4"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_061_w2aab3b7c73b1b6b1ab2b2c60Aa","doi-asserted-by":"crossref","unstructured":"Moulder, K.L., Narita, M., Chang, L.K., Bu, G., and Johnson, E.M., Jr. (1999). Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J. Neurochem. 72: 1069\u20131080, https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0721069.x.","DOI":"10.1046\/j.1471-4159.1999.0721069.x"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_062_w2aab3b7c73b1b6b1ab2b2c61Aa","doi-asserted-by":"crossref","unstructured":"Munoz, S.S., Garner, B., and Ooi, L. (2019). Understanding the Role of ApoE Fragments in Alzheimer's Disease. Neurochem. Res. 44: 1297\u20131305, https:\/\/doi.org\/10.1007\/s11064-018-2629-1.","DOI":"10.1007\/s11064-018-2629-1"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_063_w2aab3b7c73b1b6b1ab2b2c62Aa","doi-asserted-by":"crossref","unstructured":"Munoz, S.S., Li, H., Ruberu, K., Chu, Q., Saghatelian, A., Ooi, L., and Garner, B. (2018). The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis. J. Biol. Chem. 293: 4071\u20134084, https:\/\/doi.org\/10.1074\/jbc.ra117.001278.","DOI":"10.1074\/jbc.RA117.001278"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_064_w2aab3b7c73b1b6b1ab2b2c63Aa","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Watanabe, A., Fujino, T., Hosono, T., and Michikawa, M. (2009). Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol. Neurodegener. 4: 35, https:\/\/doi.org\/10.1186\/1750-1326-4-35.","DOI":"10.1186\/1750-1326-4-35"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_065_w2aab3b7c73b1b6b1ab2b2c64Aa","doi-asserted-by":"crossref","unstructured":"O'Brien, R.J. and Wong, P.C. (2011). Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 34: 185\u2013204, https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613.","DOI":"10.1146\/annurev-neuro-061010-113613"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_066_w2aab3b7c73b1b6b1ab2b2c65Aa","doi-asserted-by":"crossref","unstructured":"Raber, J., Huang, Y., and Ashford, J.W. (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging. 25: 641\u2013650, https:\/\/doi.org\/10.1016\/j.neurobiolAging.2003.12.023.","DOI":"10.1016\/j.neurobiolaging.2003.12.023"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_067_w2aab3b7c73b1b6b1ab2b2c66Aa","doi-asserted-by":"crossref","unstructured":"Raulin, A.C., Kraft, L., Al-Hilaly, Y.K., Xue, W.F., McGeehan, J.E., Atack, J.R., and Serpell, L. (2019). The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease. J. Mol. Biol. 431: 2248\u20132265, https:\/\/doi.org\/10.1016\/j.jmb.2019.04.019.","DOI":"10.1016\/j.jmb.2019.04.019"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_068_w2aab3b7c73b1b6b1ab2b2c67Aa","doi-asserted-by":"crossref","unstructured":"Readnower, R.D., Sauerbeck, A.D., and Sullivan, P.G. (2011). Mitochondria, Amyloid \u03b2, and Alzheimer's Disease. Int. J. Alzheimers Dis. 2011: 104545, https:\/\/doi.org\/10.4061\/2011\/104545.","DOI":"10.4061\/2011\/104545"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_069_w2aab3b7c73b1b6b1ab2b2c68Aa","doi-asserted-by":"crossref","unstructured":"Rohn, T.T., Catlin, L.W., Coonse, K.G., and Habig, J.W. (2012). Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Brain Res. 1475: 106\u2013115, https:\/\/doi.org\/10.1016\/j.brainres.2012.08.003.","DOI":"10.1016\/j.brainres.2012.08.003"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_070_w2aab3b7c73b1b6b1ab2b2c69Aa","doi-asserted-by":"crossref","unstructured":"Sakono, M. and Zako, T. (2010). Amyloid oligomers: formation and toxicity of A\u03b2 oligomers. FEBS J. 277: 1348\u20131358, https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07568.x.","DOI":"10.1111\/j.1742-4658.2010.07568.x"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_071_w2aab3b7c73b1b6b1ab2b2c70Aa","doi-asserted-by":"crossref","unstructured":"Tamboli, I.Y., Heo, D., and Rebeck, G.W. (2014). Extracellular proteolysis of apolipoprotein e (apoE) by secreted serine neuronal protease. PLoS One. 9: e93120, https:\/\/doi.org\/10.1371\/journal.pone.0093120.","DOI":"10.1371\/journal.pone.0093120"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_072_w2aab3b7c73b1b6b1ab2b2c71Aa","doi-asserted-by":"crossref","unstructured":"Tolar, M., Keller, J.N., Chan, S., Mattson, M.P., Marques, M.A., and Crutcher, K.A. (1999). Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci. 19: 7119\u20137110, https:\/\/doi.org\/10.1523\/jneurosci.19-16-07100.1999.","DOI":"10.1523\/JNEUROSCI.19-16-07100.1999"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_073_w2aab3b7c73b1b6b1ab2b2c72Aa","doi-asserted-by":"crossref","unstructured":"Tolar, M., Marques, M.A., Harmony, J.A.K., and Crutcher, K.A. (1997). Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17: 5678\u20135686, https:\/\/doi.org\/10.1523\/jneurosci.17-15-05678.1997.","DOI":"10.1523\/JNEUROSCI.17-15-05678.1997"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_074_w2aab3b7c73b1b6b1ab2b2c73Aa","doi-asserted-by":"crossref","unstructured":"Varon, D., Loewenstein, D.A., Potter, E., Greig, M.T., Agron, J., Shen, Q., Zhao, W., Celeste Ramirez, M., Santos, I., Barker, W., et al. (2011). Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment. Dement Geriatr. Cogn. Disord. 31: 276\u2013283, https:\/\/doi.org\/10.1159\/000324711.","DOI":"10.1159\/000324711"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_075_w2aab3b7c73b1b6b1ab2b2c74Aa","doi-asserted-by":"crossref","unstructured":"Wang, C., Najm, R., Xu, Q., Jeong, D.E., Walker, D., Balestra, M.E., Yoon, S.Y., Yuan, H., Li, G., Miller, Z.A., et al. (2018). Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24: 647\u2013657, https:\/\/doi.org\/10.1038\/s41591-018-0004-z.","DOI":"10.1038\/s41591-018-0004-z"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_076_w2aab3b7c73b1b6b1ab2b2c75Aa","doi-asserted-by":"crossref","unstructured":"Wang, M. and Turko, I.V. (2013). Mass Spectrometry Quantification Revealed Accumulation of C-Terminal Fragment of Apolipoprotein E in the Alzheimer's Frontal Cortex. PLoS One. 8: e61498, https:\/\/doi.org\/10.1371\/journal.pone.0061498.","DOI":"10.1371\/journal.pone.0061498"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_077_w2aab3b7c73b1b6b1ab2b2c76Aa","doi-asserted-by":"crossref","unstructured":"Wellnitz, S., Friedlein, A., Bonanni, C., Anquez, V., Goepfert, F., Loetscher, H., Adessi, C., and Czech, C. (2005). A 13 kDa carboxy-terminal fragment of ApoE stabilizes Abeta hexamers. J. Neurochem. 94: 1351\u20131360, https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03295.x.","DOI":"10.1111\/j.1471-4159.2005.03295.x"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_078_w2aab3b7c73b1b6b1ab2b2c77Aa","doi-asserted-by":"crossref","unstructured":"Wisniewski, T., Lalowski, M., Golabek, A., Frangione, B., and Vogel, T. (1995). Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 345: 956\u2013958, https:\/\/doi.org\/10.1016\/s0140-6736(95)90701-7.","DOI":"10.1016\/S0140-6736(95)90701-7"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_079_w2aab3b7c73b1b6b1ab2b2c78Aa","doi-asserted-by":"crossref","unstructured":"Wolff, M., Zhang-Haagen, B., Decker, C., Barz, B., Schneider, M., Biehl, R., Radulescu, A., Strodel, B., Willbold, D., and Nagel-Steger, L. (2017). A\u03b242 pentamers\/hexamers are the smallest detectable oligomers in solution. Sci. Rep. 7: 2493, https:\/\/doi.org\/10.1038\/s41598-017-02370-3.","DOI":"10.1038\/s41598-017-02370-3"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_080_w2aab3b7c73b1b6b1ab2b2c79Aa","doi-asserted-by":"crossref","unstructured":"Youssef, P., Chami, B., Lim, J., Middleton, T., Sutherland, G.T., and Witting, P.K. (2018). Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease. Sci. Rep. 8: 11553, https:\/\/doi.org\/10.1038\/s41598-018-29770-3.","DOI":"10.1038\/s41598-018-29770-3"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_081_w2aab3b7c73b1b6b1ab2b2c80Aa","doi-asserted-by":"crossref","unstructured":"Zhang, Y.W., Thompson, R., Zhang, H., and Xu, H. (2011). APP processing in Alzheimer's disease. Mol. Brain. 4: 3, https:\/\/doi.org\/10.1007\/978-0-387-35135-3_2.","DOI":"10.1186\/1756-6606-4-3"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_082_w2aab3b7c73b1b6b1ab2b2c81Aa","doi-asserted-by":"crossref","unstructured":"Zhao, J., Davis, M.D., Martens, Y.A., Shinohara, M., Graff-Radford, N.R., Younkin, S.G., Wszolek, Z.K., Kanekiyo, T., and Bu, G. (2017). APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum. Mol. Genet. 26: 2690\u20132700, https:\/\/doi.org\/10.1093\/hmg\/ddx155.","DOI":"10.1093\/hmg\/ddx155"},{"key":"2023040102342476829_j_revneuro-2019-0115_ref_083_w2aab3b7c73b1b6b1ab2b2c82Aa","doi-asserted-by":"crossref","unstructured":"Zhou, W., Scott, S.A., Shelton, S.B., and Crutcher, K.A. (2006). Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer's disease. Neuroscience. 143: 689\u2013701, https:\/\/doi.org\/10.1016\/j.neuroscience.2006.08.019.","DOI":"10.1016\/j.neuroscience.2006.08.019"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/revneuro\/31\/6\/article-p589.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0115\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0115\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T03:53:34Z","timestamp":1680407614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0115\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":82,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,8,27]]}},"alternative-id":["10.1515\/revneuro-2019-0115"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2019-0115","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"value":"2191-0200","type":"electronic"},{"value":"0334-1763","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}